Anson Funds Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
189,000
-117,000
-38% -$2.75M 0.29% 70
2026
Q1
$4.58M Buy
+306,000
New +$5.22M 0.4% 55
2025
Q2
Sell
-95,100
Closed -$689K 112
2025
Q1
$689K Buy
+95,100
New +$1.08M 0.13% 97
2024
Q4
Sell
-307,000
Closed -$3.64M 163
2024
Q3
$3.64M Buy
+307,000
New +$3.18M 0.36% 43
2024
Q2
Sell
-282,559
Closed -$1M 163
2024
Q1
$1M Buy
+282,559
New +$980K 0.06% 102

Other funds holding CORZ

Anson Funds Management's CORZ Position: Q2 2026 in Review

Anson Funds Management reduced its Core Scientific (CORZ) stake by 38% in Q2 2026, selling an estimated $2.75M and leaving 189,000 shares worth $4.84M. The position accounts for 0.29% of the portfolio, ranked #70.

Anson Funds Management first reported a position in CORZ in Q1 2024 and has held it in 5 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Anson Funds Management held 189,000 shares of Core Scientific worth $4.84M as of Q2 2026.
  • Anson Funds Management sold 117,000 Core Scientific shares in Q2 2026, an estimated $2.75M.
  • Core Scientific made up 0.29% of Anson Funds Management's portfolio in Q2 2026, its #70 holding.
  • Anson Funds Management first reported a position in Core Scientific in Q1 2024 and has held it in 5 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Anson Funds Management's 13F filing for Q2 2026, filed 13 Aug 2026.